natamycin

komponim kimik

External resources

Freebase ID
Microsoft Academic ID
PubChem CID
MeSH descriptor ID
D010866

referuar si: Natamycin

UniChem compound ID
KEGG ID
Encyclopædia Britannica Online ID
topic/natamycin

referuar si: natamycin

kodi ATC
WikiProjectMed ID
PesticideInfo chemical ID
RxNorm ID
Open Food Facts food additive ID
UNSPSC Code
NSC number
OpenAlex ID
ChEMBL ID
numri CAS
Natural Product Atlas ID
InChIKey
DrugBank ID
E number
ChEBI ID
7488[14][15][16]

mapping relation type: përputhje e përpiktë

InChI
CosIng number
electronic Essential Medicines List medicine ID
Brockhaus Enzyklopädie online ID
SureChEMBL ID
Human Metabolome Database ID
MeSH tree code
UMLS CUI
SPLASH
Open Food Facts ingredient ID
Store medisinske leksikon ID
natamycin[19]

referuar si: natamycin

mapping relation type: përputhje e përpiktë

DSSTOX compound identifier
DSSTox substance ID
ECHA Substance Infocard ID
ChemSpider ID
numri CE
DrugCentral ID
NDF-RT ID
NALT ID
Encyclopedia of China (Third Edition) ID
Probes And Drugs ID
UNII

instancë e

type of chemical entity

nënklasë e

polyene macrolide

strukturë kimike

masa

665,305 dalton[2]

stereoisomer of

(1R,3S,5R,7R,12R,22R,24S,25R,26S)-22-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid[12][24]

formula kimike

C₃₃H₄₇NO₁₃[2]

kanonikja SMILES

CC1CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC3C(O3)C=CC(=O)O1)O)O)O)C(=O)O)OC4C(C(C(C(O4)C)O)N)O[2]

isomeric SMILES

C[C@@H]1C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@@H]3[C@H](O3)/C=C/C(=O)O1)O)O)O)C(=O)O)O[C@H]4[C@H]([C@H]([C@@H]([C@H](O4)C)O)N)O[2]

defined daily dose

25 milligram[25]

route of administration: intravaginal administration

0,3 grami[26]

route of administration: oral administration

20 milligram[27]

route of administration: oral administration

active ingredient in

Natacyn[28]

World Health Organisation international non-proprietary name

natamycin[6]

medical condition treated

conjunctivitis[54]
coccidioidomycosis[54]
aspergillosis[54]
fungal infectious disease[54]
blepharitis[54]
microsporidiosis[54]
blastomycosis[54]
cryptococcosis[54]
sporotrichosis[54]
histoplasmosis[54]
keratitis[54]
keratitis[55]

approved by: Food and Drug Administration

koha e fillimit: 13 qershor 1980

conjunctivitis[55]

approved by: Food and Drug Administration

koha e fillimit: 13 qershor 1980

blepharitis[55]

approved by: Food and Drug Administration

koha e fillimit: 13 qershor 1980

subjekti ka rol

local anti-infective agent[56]
antifungal[56]
essential medicine

kategoria në Commons

Natamycin

Reference

  1. ^ Freebase Data Dumps, 28 tetor 2013
  2. ^ a b c d e f g PubChem, 17 nëntor 2016, anglisht, 5284447, pimaricin
  3. ^ a b c d e f NCXMLFZGDNKEPB-FFPOYIOWSA-N, InChIKey
  4. ^ a b c d NCXMLFZGDNKEPB-BQGNJOPGSA-N, InChIKey
  5. ^ a b UniChem
  6. ^ a b ChEMBL, 19 janar 2016, anglisht, Natamycin, CHEMBL1200656
  7. ^ a b c d e DrugBank, anglisht, 17 nëntor 2015, 00826, Natamycin
  8. ^ a b c d e f Global Substance Registration System, 17 nëntor 2016, anglisht, natamycin, 8O0C852CPO
  9. ^ OpenAlex, 26 janar 2022, https://docs.openalex.org/download-snapshot/snapshot-data-format
  10. ^ ChEMBL, 17 nëntor 2016, anglisht, NATAMYCIN, CHEMBL1200656
  11. ^ CAS Common Chemistry, 10 prill 2021, https://commonchemistry.cas.org/detail?cas_rn=7681-93-8, NCXMLFZGDNKEPB-FFPOYIOWSA-N
  12. ^ a b c d e inferred from InChIKey
  13. ^ ChEBI release 2020-09-01
  14. ^ ChEBI release 2019-10-02
  15. ^ ChEBI release 2021-03-01
  16. ^ InChI=1S/C33H47NO13/c1-18-10-8-6-4-3-5-7-9-11-21(45-32-30(39)28(34)29(38)19(2)44-32)15-25-27(31(40)41)22(36)17-33(42,47-25)16-20(35)14-24-23(46-24)12-13-26(37)43-18/h3-9,11-13,18-25,27-30,32,35-36,38-39,42H,10,14-17,34H2,1-2H3,(H,40,41)/b4-3+,7-5+,8-6+,11-9+,13-12+/t18-,19-,20+,21+,22+,23-,24-,25+,27-,28+,29-,30+,32+,33-/m1/s1, International Chemical Identifier
  17. ^ CosIng database, 28 dhjetor 2019, 91607, NATAMYCIN, CAS no.: 7681-93-8
  18. ^ https://list.essentialmeds.org/medicines/230, eEML - Electronic Essential Medicines List, 23 tetor 2021
  19. ^ Great Norwegian Encyclopedia, 5 qershor 2020
  20. ^ Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard
  21. ^ ECHA Substance Infocard database, 27 dhjetor 2018, 100.028.803, Natamycin, CAS no.: 7681-93-8
  22. ^ ChemSpider, 17 nëntor 2016, anglisht, 10468784, Natamycin
  23. ^ DrugBank, anglisht, 17 nëntor 2015, Natamycin, 00826
  24. ^ inferred from InChI
  25. ^ https://www.whocc.no/atc_ddd_index/?code=G01AA02
  26. ^ https://www.whocc.no/atc_ddd_index/?code=A07AA03
  27. ^ https://www.whocc.no/atc_ddd_index/?code=A01AB10
  28. ^ RxNorm, 202743, 14 shkurt 2018
  29. ^ The structure of the macrolide antibiotic pimaricin
  30. ^ a b c d Enhancement of natamycin production on Streptomyces gilvosporeus by chromosomal integration of the Vitreoscilla hemoglobin gene (vgb).
  31. ^ a b c d Bidirectional Regulation of AdpAch in Controlling the Expression of scnRI and scnRII in the Natamycin Biosynthesis of Streptomyces chattanoogensis L10.
  32. ^ a b c d Improvement of Natamycin Production by Cholesterol Oxidase Overexpression in Streptomyces gilvosporeus
  33. ^ a b c d Multiple transporters are involved in natamycin efflux in Streptomyces chattanoogensis L10.
  34. ^ a b c d Improvement of natamycin production by engineering of phosphopantetheinyl transferases in Streptomyces chattanoogensis L10.
  35. ^ a b c d Enhanced Natamycin production by Streptomyces natalensis in shake-flasks and stirred tank bioreactor under batch and fed-batch conditions
  36. ^ a b c d Physicochemical and microbial responses of Streptomyces natalensis HW-2 to fungal elicitor
  37. ^ a b c d Production of natamycin by Streptomyces gilvosporeus Z28 through solid-state fermentation using agro-industrial residues
  38. ^ a b c d Rational construction of genome-reduced and high-efficient industrial Streptomyces chassis based on multiple comparative genomic approaches
  39. ^ a b c d Complete Genome Sequence of the High-Natamycin-Producing Strain Streptomyces gilvosporeus F607.
  40. ^ a b c d WblAch, a pivotal activator of natamycin biosynthesis and morphological differentiation in Streptomyces chattanoogensis L10, is positively regulated by AdpAch
  41. ^ a b c d Effects of cultivation conditions on the production of natamycin with Streptomyces gilvosporeus LK-196.
  42. ^ a b c d Genome mining and homologous comparison strategy for digging exporters contributing self-resistance in natamycin-producing Streptomyces strains
  43. ^ a b c d Solubility properties and diffusional extraction behavior of natamycin from Streptomyces gilvosporeus biomass
  44. ^ a b c d Genome-wide analysis of the regulation of pimaricin production in Streptomyces natalensis by reactive oxygen species.
  45. ^ a b c d Construction of a Streptomyces lydicus A01 transformant with a chit42 gene from Trichoderma harzianum P1 and evaluation of its biocontrol activity against Botrytis cinerea.
  46. ^ a b c d Influence of fungal elicitors on biosynthesis of natamycin by Streptomyces natalensis HW-2
  47. ^ a b c d SlnM gene overexpression with different promoters on natamycin production in Streptomyces lydicus A02.
  48. ^ a b c d Characterization of type II thioesterases involved in natamycin biosynthesis in Streptomyces chattanoogensis L10.
  49. ^ a b c d Biosynthesis regulation of natamycin production from Streptomyces natalensis HDMNTE-01 enhanced by response surface methodology.
  50. ^ a b c d Identification of a secondary metabolism-responsive promoter by proteomics for over-production of natamycin in Streptomyces
  51. ^ A complex multienzyme system encoded by five polyketide synthase genes is involved in the biosynthesis of the 26-membered polyene macrolide pimaricin in Streptomyces natalensis
  52. ^ Iteratively improving natamycin production in Streptomyces gilvosporeus by a large operon-reporter based strategy
  53. ^ AB-400, a new tetraene macrolide isolated from Streptomyces costae
  54. ^ a b c d e f g h i j k l N0000146913, 13 dhjetor 2016, anglisht, NDF-RT
  55. ^ a b c Inxight: Drugs Database, 2 nëntor 2018, https://drugs.ncats.io/drug/8O0C852CPO, http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050514s009lbl.pdf
  56. ^ a b c Medical Subject Headings, 15 mars 2018, D010866